{"id":8464,"date":"2024-12-01T08:10:03","date_gmt":"2024-12-01T07:10:03","guid":{"rendered":"https:\/\/www.mirdetect.de\/?p=8464"},"modified":"2025-10-21T11:25:17","modified_gmt":"2025-10-21T09:25:17","slug":"foerderung-krebsdiagnostik","status":"publish","type":"post","link":"https:\/\/www.mirdetect.de\/en\/foerderung-krebsdiagnostik\/","title":{"rendered":"Promotion"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n

Bremerhaven, December 2024<\/strong>\u00a0- The Bremerhaven-based biotechnology company mir|detect GmbH<\/strong> receives a grant in the amount of 175,781.92 euros<\/strong> through the BIS Business Development Bremerhaven<\/strong>co-financed by funds from the European Union (EFRE)<\/strong>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n

The two-year research project \"Identification of new nucleic acid biomarkers for use in liquid biopsy tests<\/strong>\" runs from the 1 December 2024 to 30 November 2026<\/strong> and strengthens the development of innovative solutions in the area of molecular cancer diagnostics<\/strong>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Project objective: Earlier and more precise cancer diagnosis through liquid biopsy<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The aim of the project is to identify new circulating nucleic acid biomarkers in the blood that enable the non-invasive and highly precise early detection of cancer. The focus is on pancreatic carcinoma (pancreatic cancer) and urothelial carcinoma (bladder cancer) - two tumor types for which no reliable blood tests are currently available.<\/p>\n

In order to achieve this goal mir|detect<\/strong> RNA sequencing (RNA-seq) on clinical samples. The most promising biomarkers are then analysed using the company's proprietary and patented panta|Q\u00ae<\/sup> Technology<\/strong> into a prototype in-vitro diagnostic (IVD). The test system is verified in a proof-of-concept study, followed by comprehensive testing of the analytical performance parameters in accordance with the requirements of the Regulation (EU) 2017\/746 IVDR<\/strong>.<\/p>\n

The end point of the project is the development of a fully tested and verified IVD prototype that fulfils all the technical and analytical requirements for a clinical trial and subsequent CE-IVD certification. This will create the basis for bringing liquid biopsy tests for various types of cancer onto the market in the future.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Significance for Bremerhaven as a biotechnology center<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The project strengthens Bremerhaven as a biotechnology centre and creates new, highly qualified jobs in research and development. Through co-operation with Bremerhaven University of Applied Sciences and the University of Bremen, mir|detect also promotes the regional transfer of knowledge and the training of young specialists in the field of molecular diagnostics.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Bremerhaven, Dezember 2024\u00a0\u2013 Die Bremerhavener Biotechnologie-Firma mir|detect GmbH erh\u00e4lt eine F\u00f6rderung in H\u00f6he von 175.781,92 Euro durch die BIS Wirtschaftsf\u00f6rderung Bremerhaven, kofinanziert durch Mittel der Europ\u00e4ischen Union (EFRE). Das zweij\u00e4hrige Forschungsprojekt \u201eIdentifikation neuer Nukleins\u00e4ure-Biomarker zur Nutzung in Liquid Biopsy-Tests\u201c l\u00e4uft vom 1. Dezember 2024 bis 30. November 2026 und st\u00e4rkt die Entwicklung innovativer L\u00f6sungen im […]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[1],"tags":[],"class_list":["post-8464","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nKrebsdiagnostik F\u00f6rderung - mir|detect<\/title>\n<meta name=\"description\" content=\"mir|detect entwickelt mit EU-F\u00f6rderung neue Liquid-Biopsy-Tests f\u00fcr eine pr\u00e4zisere, nicht-invasive Krebsdiagnostik \u2013 made in Bremerhaven.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mirdetect.de\/en\/foerderung-krebsdiagnostik\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Krebsdiagnostik F\u00f6rderung - mir|detect\" \/>\n<meta property=\"og:description\" content=\"mir|detect entwickelt mit EU-F\u00f6rderung neue Liquid-Biopsy-Tests f\u00fcr eine pr\u00e4zisere, nicht-invasive Krebsdiagnostik \u2013 made in Bremerhaven.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mirdetect.de\/en\/foerderung-krebsdiagnostik\/\" \/>\n<meta property=\"og:site_name\" content=\"mir|detect\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-01T07:10:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-21T09:25:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mirdetect.de\/wp-content\/uploads\/2023\/02\/Logo-fuer-BIS_2-Kopie.jpg\" \/>\n<meta name=\"author\" content=\"Frank Dorsch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frank Dorsch\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/\"},\"author\":{\"name\":\"Frank Dorsch\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#\\\/schema\\\/person\\\/1360538a5c60c0f968ceb4bc409e35ed\"},\"headline\":\"F\u00f6rderung\",\"datePublished\":\"2024-12-01T07:10:03+00:00\",\"dateModified\":\"2025-10-21T09:25:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/\"},\"wordCount\":281,\"publisher\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mirdetect.de\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Logo-fuer-BIS_2-Kopie.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/\",\"url\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/\",\"name\":\"Krebsdiagnostik F\u00f6rderung - mir|detect\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mirdetect.de\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Logo-fuer-BIS_2-Kopie.jpg\",\"datePublished\":\"2024-12-01T07:10:03+00:00\",\"dateModified\":\"2025-10-21T09:25:17+00:00\",\"description\":\"mir|detect entwickelt mit EU-F\u00f6rderung neue Liquid-Biopsy-Tests f\u00fcr eine pr\u00e4zisere, nicht-invasive Krebsdiagnostik \u2013 made in Bremerhaven.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mirdetect.de\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Logo-fuer-BIS_2-Kopie.jpg\",\"contentUrl\":\"https:\\\/\\\/www.mirdetect.de\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Logo-fuer-BIS_2-Kopie.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/foerderung-krebsdiagnostik\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.mirdetect.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6rderung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#website\",\"url\":\"https:\\\/\\\/www.mirdetect.de\\\/\",\"name\":\"mir|detect\",\"description\":\"Die Zukunft der Hodenkrebsdiagnostik\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mirdetect.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#organization\",\"name\":\"mir|detect\",\"url\":\"https:\\\/\\\/www.mirdetect.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"mir|detect\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/soelarenergie\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.mirdetect.de\\\/#\\\/schema\\\/person\\\/1360538a5c60c0f968ceb4bc409e35ed\",\"name\":\"Frank Dorsch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2face0bfe7dbc8eb06d60377dfe4a041a5a74056e2754fd50c96ad69860b9c6a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2face0bfe7dbc8eb06d60377dfe4a041a5a74056e2754fd50c96ad69860b9c6a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2face0bfe7dbc8eb06d60377dfe4a041a5a74056e2754fd50c96ad69860b9c6a?s=96&d=mm&r=g\",\"caption\":\"Frank Dorsch\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Krebsdiagnostik F\u00f6rderung - mir|detect","description":"mir|detect entwickelt mit EU-F\u00f6rderung neue Liquid-Biopsy-Tests f\u00fcr eine pr\u00e4zisere, nicht-invasive Krebsdiagnostik \u2013 made in Bremerhaven.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mirdetect.de\/en\/foerderung-krebsdiagnostik\/","og_locale":"en_GB","og_type":"article","og_title":"Krebsdiagnostik F\u00f6rderung - mir|detect","og_description":"mir|detect entwickelt mit EU-F\u00f6rderung neue Liquid-Biopsy-Tests f\u00fcr eine pr\u00e4zisere, nicht-invasive Krebsdiagnostik \u2013 made in Bremerhaven.","og_url":"https:\/\/www.mirdetect.de\/en\/foerderung-krebsdiagnostik\/","og_site_name":"mir|detect","article_published_time":"2024-12-01T07:10:03+00:00","article_modified_time":"2025-10-21T09:25:17+00:00","og_image":[{"url":"https:\/\/www.mirdetect.de\/wp-content\/uploads\/2023\/02\/Logo-fuer-BIS_2-Kopie.jpg","type":"","width":"","height":""}],"author":"Frank Dorsch","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frank Dorsch","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#article","isPartOf":{"@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/"},"author":{"name":"Frank Dorsch","@id":"https:\/\/www.mirdetect.de\/#\/schema\/person\/1360538a5c60c0f968ceb4bc409e35ed"},"headline":"F\u00f6rderung","datePublished":"2024-12-01T07:10:03+00:00","dateModified":"2025-10-21T09:25:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/"},"wordCount":281,"publisher":{"@id":"https:\/\/www.mirdetect.de\/#organization"},"image":{"@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mirdetect.de\/wp-content\/uploads\/2023\/02\/Logo-fuer-BIS_2-Kopie.jpg","articleSection":["News"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/","url":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/","name":"Krebsdiagnostik F\u00f6rderung - mir|detect","isPartOf":{"@id":"https:\/\/www.mirdetect.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#primaryimage"},"image":{"@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mirdetect.de\/wp-content\/uploads\/2023\/02\/Logo-fuer-BIS_2-Kopie.jpg","datePublished":"2024-12-01T07:10:03+00:00","dateModified":"2025-10-21T09:25:17+00:00","description":"mir|detect entwickelt mit EU-F\u00f6rderung neue Liquid-Biopsy-Tests f\u00fcr eine pr\u00e4zisere, nicht-invasive Krebsdiagnostik \u2013 made in Bremerhaven.","breadcrumb":{"@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#primaryimage","url":"https:\/\/www.mirdetect.de\/wp-content\/uploads\/2023\/02\/Logo-fuer-BIS_2-Kopie.jpg","contentUrl":"https:\/\/www.mirdetect.de\/wp-content\/uploads\/2023\/02\/Logo-fuer-BIS_2-Kopie.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.mirdetect.de\/foerderung-krebsdiagnostik\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.mirdetect.de\/"},{"@type":"ListItem","position":2,"name":"F\u00f6rderung"}]},{"@type":"WebSite","@id":"https:\/\/www.mirdetect.de\/#website","url":"https:\/\/www.mirdetect.de\/","name":"mir|detect","description":"The future of testicular cancer diagnostics","publisher":{"@id":"https:\/\/www.mirdetect.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mirdetect.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.mirdetect.de\/#organization","name":"mir|detect","url":"https:\/\/www.mirdetect.de\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.mirdetect.de\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"mir|detect"},"image":{"@id":"https:\/\/www.mirdetect.de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/soelarenergie\/"]},{"@type":"Person","@id":"https:\/\/www.mirdetect.de\/#\/schema\/person\/1360538a5c60c0f968ceb4bc409e35ed","name":"Frank Dorsch","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/2face0bfe7dbc8eb06d60377dfe4a041a5a74056e2754fd50c96ad69860b9c6a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2face0bfe7dbc8eb06d60377dfe4a041a5a74056e2754fd50c96ad69860b9c6a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2face0bfe7dbc8eb06d60377dfe4a041a5a74056e2754fd50c96ad69860b9c6a?s=96&d=mm&r=g","caption":"Frank Dorsch"}}]}},"_links":{"self":[{"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/posts\/8464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/comments?post=8464"}],"version-history":[{"count":7,"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/posts\/8464\/revisions"}],"predecessor-version":[{"id":8538,"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/posts\/8464\/revisions\/8538"}],"wp:attachment":[{"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/media?parent=8464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/categories?post=8464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mirdetect.de\/en\/wp-json\/wp\/v2\/tags?post=8464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}